TGFB1 and neoplasm: Platelet-derived α-granules, containing TGFβ have been demonstrated to increase the growth of primary tumours in ovarian mouse models [39,40], while inhibiting TGFβ signalling in the tumour cell or blocking its expression in platelets has been shown to inhibit metastasis and EMT [23].